Given that TNF-α signaling amplifies IL-6 and IL-8 secretion in the CRC TME, fostering apt conditions for tumor invasion [219], it is imperative to evaluate OC’s capacity to attenuate this cytokine axis. The gene discussed is IL6; the disease is neoplasm.